U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 258

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr9:100190748-103062956
Familial thoracic aortic aneurysm and aortic dissection, ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14
Uncertain significance
(Aug 10, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr9:101984096
GRCh38:
Chr9:99221814
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Aug 26, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr9:101983809
GRCh38:
Chr9:99221527
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Oct 17, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr9:101980549
GRCh38:
Chr9:99218267
ALG2Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationLikely benign
(May 4, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr9:101984030
GRCh38:
Chr9:99221748
ALG2I49MCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Oct 17, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr9:101981116
GRCh38:
Chr9:99218834
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Jul 24, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr9:101984081
GRCh38:
Chr9:99221799
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Sep 2, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr9:101984135
GRCh38:
Chr9:99221853
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Jul 1, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr9:101983853
GRCh38:
Chr9:99221571
ALG2Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationLikely benign
(Oct 1, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr9:101983894
GRCh38:
Chr9:99221612
ALG2V95IALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jul 18, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr9:101984042
GRCh38:
Chr9:99221760
ALG2Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationLikely benign
(Dec 31, 2021)
criteria provided, single submitter
12.
GRCh37:
Chr9:101980626
GRCh38:
Chr9:99218344
ALG2Y281HALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Aug 5, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr9:101980738
GRCh38:
Chr9:99218456
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Jul 7, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr9:101980917
GRCh38:
Chr9:99218635
ALG2F184LCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Jul 12, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr9:101980503
GRCh38:
Chr9:99218221
ALG2P322TCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Aug 21, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr9:101984174
GRCh38:
Chr9:99221892
ALG2M1IALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jan 17, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr9:101984120
GRCh38:
Chr9:99221838
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Sep 1, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr9:101983913
GRCh38:
Chr9:99221631
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Oct 11, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr9:101980334
GRCh38:
Chr9:99218052
ALG2R378HALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(May 12, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr9:101980287
GRCh38:
Chr9:99218005
ALG2V394LALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Mar 13, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr9:101983942
GRCh38:
Chr9:99221660
ALG2L79VCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Jul 13, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr9:101984033
GRCh38:
Chr9:99221751
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Apr 12, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr9:101980716-101980717
GRCh38:
Chr9:99218434-99218435
ALG2R251CALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Mar 23, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr9:101980721
GRCh38:
Chr9:99218439
ALG2Q249RALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Mar 20, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr9:101980405
GRCh38:
Chr9:99218123
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Mar 14, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr9:101980801
GRCh38:
Chr9:99218519
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Oct 31, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr9:101983895
GRCh38:
Chr9:99221613
ALG2M94ICongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Feb 12, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr9:101983849
GRCh38:
Chr9:99221567
ALG2D110HCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Feb 10, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr9:101981015
GRCh38:
Chr9:99218733
ALG2L151PCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Feb 9, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr9:101983861
GRCh38:
Chr9:99221579
ALG2D106NALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jan 18, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr9:101980326-101980327
GRCh38:
Chr9:99218044-99218045
ALG2S381TCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Sep 26, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr9:101981085
GRCh38:
Chr9:99218803
ALG2R128GCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Feb 19, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr9:101980807
GRCh38:
Chr9:99218525
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Mar 23, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr9:101980357
GRCh38:
Chr9:99218075
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Sep 4, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr9:101981077-101981079
GRCh38:
Chr9:99218795-99218797
ALG2R130delALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jun 17, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr9:101984069
GRCh38:
Chr9:99221787
ALG2Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationLikely benign
(Sep 5, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr9:101980538
GRCh38:
Chr9:99218256
ALG2S310YALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jun 29, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr9:101983850
GRCh38:
Chr9:99221568
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Apr 10, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr9:101984172
GRCh38:
Chr9:99221890
ALG2A2VALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(May 19, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr9:101983869
GRCh38:
Chr9:99221587
ALG2F103fsALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Aug 9, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr9:101980496
GRCh38:
Chr9:99218214
ALG2N324SALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Apr 15, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr9:101980493
GRCh38:
Chr9:99218211
ALG2E325GCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Aug 21, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr9:101980653
GRCh38:
Chr9:99218371
ALG2E272KCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Jul 27, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr9:101980518
GRCh38:
Chr9:99218236
ALG2C317RALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jun 15, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr9:101983871
GRCh38:
Chr9:99221589
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Jun 10, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr9:101984080
GRCh38:
Chr9:99221798
ALG2V33LALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jun 28, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr9:101984045
GRCh38:
Chr9:99221763
ALG2C45fsALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(May 25, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr9:101984059
GRCh38:
Chr9:99221777
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Sep 24, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr9:101980594
GRCh38:
Chr9:99218312
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Oct 23, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr9:101981108
GRCh38:
Chr9:99218826
ALG2C120YCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Jul 17, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr9:101983840
GRCh38:
Chr9:99221558
ALG2V113MALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jul 19, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr9:101980545-101980546
GRCh38:
Chr9:99218263-99218264
ALG2K308fsCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Apr 17, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr9:101980462
GRCh38:
Chr9:99218180
ALG2M335ICongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Jan 19, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr9:101980232
GRCh38:
Chr9:99217950
ALG2T412NCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Jan 16, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr9:101980776
GRCh38:
Chr9:99218494
ALG2I231VALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jan 15, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr9:101983925-101983926
GRCh38:
Chr9:99221643-99221644
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Aug 20, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr9:101980792
GRCh38:
Chr9:99218510
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(May 28, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr9:101983998
GRCh38:
Chr9:99221716
ALG2F60YALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(May 19, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr9:101980907
GRCh38:
Chr9:99218625
ALG2T187IALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jun 22, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr9:101984030
GRCh38:
Chr9:99221748
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Jul 11, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr9:101984143
GRCh38:
Chr9:99221861
ALG2V12LALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Aug 16, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr9:101983885
GRCh38:
Chr9:99221603
ALG2A98TALG2-congenital disorder of glycosylationUncertain significance
(May 21, 2020)
criteria provided, single submitter
63.
GRCh37:
Chr9:101980453
GRCh38:
Chr9:99218171
ALG2Q338HALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Aug 11, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr9:101980877
GRCh38:
Chr9:99218595
ALG2D197GALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jul 30, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr9:101983994
GRCh38:
Chr9:99221712
ALG2Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationLikely benign
(Oct 5, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr9:101980276
GRCh38:
Chr9:99217994
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Mar 22, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr9:101984144
GRCh38:
Chr9:99221862
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Aug 22, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr9:101983821
GRCh38:
Chr9:99221539
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Aug 24, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr9:101981041
GRCh38:
Chr9:99218759
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Nov 1, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr9:101983964
GRCh38:
Chr9:99221682
ALG2Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationLikely benign
(Feb 28, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr9:101980810
GRCh38:
Chr9:99218528
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Sep 24, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr9:101983979
GRCh38:
Chr9:99221697
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Dec 24, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr9:101983809
GRCh38:
Chr9:99221527
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Sep 15, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr9:101984108
GRCh38:
Chr9:99221826
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Oct 2, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr9:101984171
GRCh38:
Chr9:99221889
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Nov 11, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr9:101984107
GRCh38:
Chr9:99221825
ALG2Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationLikely benign
(Aug 3, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr9:101983815
GRCh38:
Chr9:99221533
ALG2Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationLikely benign
(Mar 4, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr9:101981092
GRCh38:
Chr9:99218810
ALG2Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationLikely benign
(Feb 2, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr9:101980896
GRCh38:
Chr9:99218614
ALG2Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationLikely benign
(May 18, 2021)
criteria provided, single submitter
80.
GRCh37:
Chr9:101981065
GRCh38:
Chr9:99218783
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Likely benign
(Dec 2, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr9:101980442
GRCh38:
Chr9:99218160
ALG2I342TCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Aug 23, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr9:101983960
GRCh38:
Chr9:99221678
ALG2D73HCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Jul 6, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr9:101983913
GRCh38:
Chr9:99221631
ALG2Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationLikely benign
(Sep 1, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr9:101983830
GRCh38:
Chr9:99221548
ALG2Q116RCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Apr 25, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr9:101980848
GRCh38:
Chr9:99218566
ALG2S207GALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Nov 16, 2021)
criteria provided, single submitter
86.
GRCh37:
Chr9:101984101
GRCh38:
Chr9:99221819
ALG2V26MALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Nov 1, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr9:101980960
GRCh38:
Chr9:99218678
ALG2M169IALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Aug 30, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr9:101980734
GRCh38:
Chr9:99218452
ALG2E245KALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jun 5, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr9:101980672
GRCh38:
Chr9:99218390
ALG2I265MCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Oct 17, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr9:101983992
GRCh38:
Chr9:99221710
ALG2E62GALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jul 29, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr9:101983997
GRCh38:
Chr9:99221715
ALG2F60LALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr9:101980703
GRCh38:
Chr9:99218421
ALG2T255IALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Aug 17, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr9:101980895
GRCh38:
Chr9:99218613
ALG2L191PALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Jul 26, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr9:101984009
GRCh38:
Chr9:99221727
ALG2ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Dec 3, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr9:101980868
GRCh38:
Chr9:99218586
ALG2Y200SALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14Uncertain significance
(Sep 24, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr9:101980430
GRCh38:
Chr9:99218148
ALG2S346LInborn genetic diseases, Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation
Uncertain significance
(Jan 6, 2023)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr9:101980239
GRCh38:
Chr9:99217957
ALG2Y410HCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Jul 26, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr9:101980978
GRCh38:
Chr9:99218696
ALG2E163DCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Oct 18, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr9:101981024-101981025
GRCh38:
Chr9:99218742-99218743
ALG2D148fsCongenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylationUncertain significance
(Jul 5, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr9:101984161
GRCh38:
Chr9:99221879
ALG2G6RInborn genetic diseases, Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation
Uncertain significance
(Sep 6, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination